Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients

(2012) Hikaru Hori et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

(2012) Mark J. Millan et al.   NATURE REVIEWS DRUG DISCOVERY

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

(2012) Hitoshi Sakurai et al.   SCHIZOPHRENIA BULLETIN

Dopamine D2 Receptor Occupancy and Clinical Effects

(2011) Hiroyuki Uchida et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial

(2010) Chuan-Yue Wang et al.   AMERICAN JOURNAL OF PSYCHIATRY

Processing Speed Deficits in Schizophrenia: Reexamining the Evidence

(2010) Emma E.M. Knowles et al.   AMERICAN JOURNAL OF PSYCHIATRY

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder

(2009) D. Élie et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis

(2009) Hiroyuki Uchida et al.   SCHIZOPHRENIA BULLETIN

Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot study

(2008) Frédéric Rouillon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY